Author: Amanda Stonestreet

2015 Advocacy Award Winners: Connie and Sam Johnson

Research Australia
Health & Medical Research Awards

2015 Advocacy Award

The Advocacy Award recognises a prominent Australian who has raised community awareness about the benefits of Health & Medical Research, and the need for increased funding.

Award Winners

Connie Johnson & Samuel Johnson
Co-Founders, Love Your Sister

Connie is vibrant, loving, compassionate, tough and inspiring. She’s a mother of two beautiful boys. She’s 35 years old. And she’s dying of Breast Cancer.
.
This is her third battle with cancer. At the age 11 Connie, with the help of early detection and chemotherapy, fought off a very rare and aggressive bone tumour in her leg. At 22, she overcame a tumour in her womb, again with the help of early detection and treatment.
.
This time Connie has Breast Cancer. It has spread to her lungs, liver, pelvis, spine and knee. This time it’s terminal and she has a life expectancy of 6 – 12 months.
.
Nothing can prepare you for to say goodbye to your kids at such a young age. That’s why Connie is hard at work to raise Breast Cancer awareness. Early detection is the key to survival and Connie wants everyone to know it.
.
Samuel is one of Australia’s most recognisable personalities in the Australian entertainment industry.
.
He’s best known for his roles on The Secret Life of Us, Crackerjack, Underbelly II and Network Ten’s Rush. He’s made a number of TV guest appearances… and he’s the voice of Vodafone, Suzuki and Pedigree.
.
Plenty of career accolades have come his way. He’s enjoyed multiple Logie nominations, an AFI Award and an Australian Centenary Medal in the 2000 Queens Honours list. He’s very  proud of all of this, but none of it is as important to him as his sister.
 .

Prime Minister’s Prizes for Science 2016

The Prime Minister’s Prizes for Science are Australia’s most prestigious and highly regarded awards for outstanding achievements in scientific research, research-based innovation and excellence in science teaching.

These awards are presented by the Prime Minister and the Minister for Industry, Innovation and Science at a black-tie dinner in the Great Hall.

Continue reading “Prime Minister’s Prizes for Science 2016”

Cure Brain Cancer opens applications for their 2016 Fellowship and Scholarship awards

Cure Brain Cancer invites applications for their 2016 Fellowship and Scholarship awards as part of the Brilliant Minds program

Cure Brain Cancer Foundation is committed to encouraging brilliant minds into brain cancer research and want to attract the best and brightest to work in this challenging and rewarding field.

Continue reading “Cure Brain Cancer opens applications for their 2016 Fellowship and Scholarship awards”

Research Australia welcomes announcement of MRFF Advisory Board

Research Australia welcomes the news that the membership of the MRFF Advisory Board is to be announced today by the Health Minister, the Hon. Sussan Ley. The members are:

Professor Ian Frazer, AC (Chair)
Inaugural President of Australian Academy of Health and Medical Sciences
Former Director of the Translational Research Institute
Former Australian of the Year

Continue reading “Research Australia welcomes announcement of MRFF Advisory Board”

Michael J Fox Foundation explains the pharmaceutical development process

The Michael J. Fox Foundation‘s Co-Founder Debi Brooks breaks down the pharmaceutical development landscape in an easy to understand analogy and explains how the Foundation plays a critical role in bringing better and improved Parkinson’s disease therapies to patients.

Continue reading “Michael J Fox Foundation explains the pharmaceutical development process”

grassROOTS Magazine

Autumn 2016 Issue Out Now!

Welcome to the Autumn issue of Research Australia’s grassROOTS magazine.  Activity in our sector has been at fever pitch for a while now and there have been some good outcomes. The National Innovation and Science Agenda (NISA) was announced by the Prime Minister in early December. Research Australia welcomes this clear focus by our Government on science and innovation as essential to Australia’s future and there is no doubt that health and medical research has an important role to play.

This agenda reconfirmed the importance of the Medical Research Future Fund, it has enabled the set up of a biomedical translation fund to quickly address the funding gap for mid to later stage clinical research and development, and it is also focused on developing a new plan for research infrastructure and championing the importance of STEM subjects such as maths and science, in our education system.

Continue reading “grassROOTS Magazine”

R&D Tax Incentive Review

As part of the National Innovation & Science Agenda, the Government has commissioned Innovation and Science Australia to undertake a review of the R&D Tax Incentive.

While Research Australia proposed some possible minor amendments to the R&D Tax Incentive, we argued that on the whole the R&D Tax Incentive is already performing well against the Review’s criteria of effectiveness, integrity and encouraging additional R&D. Any changes to the R&D Tax Incentive at this point in time should be limited to improving the way it is administered.

R&D Tax Incentive Review

Tax Incentives for early stage investors

As part of the National Innovation and Science Agenda (NISA) Treasury has undertaken a consultation on an initiative to provide tax incentives for early stage investors in innovative companies. Research Australia’s submission supports the proposal and suggests some amendments to improve its operation and reduce red tape. These include making registration for the R&D Tax incentive a qualifying condition for treating a company as an ‘innovation company’ in respect of which the tax incentive can apply, and allowing the tax incentive to be available to ‘retail’ investors. The tax incentive has the potential to increase the capital available to early stage innovative companies, including those seeking to commercialise new medicines, devices and therapies.

Tax Incentives for early stage investors

Proposed reduction in Minimum Distributions for Ancillary Funds opposed

Private and Public Ancillary Funds allow individuals and organisations to create trusts that can receive tax deductible donations and then distribute these amounts to charities in later years. The Treasury proposed allowing Ancillary Funds to reduce the amount they must distribute to charities each year, and to link this amount to their investment returns. Health and Medical Research is a recipient of funds from Ancillary Funds.

Research Australia has opposed the changes because linking the funds to economic conditions and investment market performance could reduce the amount of funds made available and lead to greater year-to year-variation in distributions

Reduction in Minimum Distributions for Ancillary Funds

PCFA and the Movember Foundation announce funding for two new prostate cancer trials

Prostate Cancer Foundation Australia (PCFA) and the Movember Foundation have today announced funding towards two new clinical trials to address significant research questions that will potentially revolutionise the way prostate cancers are monitored and treated. These clinical trials involve the testing of a new scanning technique and the role of Vitamin D in preventing progression of prostate cancer.

Continue reading “PCFA and the Movember Foundation announce funding for two new prostate cancer trials”